Skip to main content

Tailoring treatment with comprehensive solid tumor solutions

Our decision-support tools help you find the best treatment plan, whether by aligning with standard of care and clinical trial options, or by helping you navigate new and emerging therapies beyond current standards of care.

 

With a range of advanced and enhanced solutions, we can help make solid tumor oncology testing more actionable and accessible.

Unlocking blood cancer insights

We offer hematology cancer testing services across the spectrum, from routine to specialized.

  • Comprehensive diagnostic services for blood and bone marrow biopsies with trending reports
  • Molecular assays, many of which were developed by our team at Quest Diagnostics® Nichols Institute
  • Cytogenetics including DNA microarrays
  • Flow cytometry, including specialty panels and PNH (paroxysmal nocturnal hemoglobinuria) testing
  • Reference menus for FISH (fluorescence in situ hybridization), IHC (immunohistochemistry), and special stains
drug-testing-podcast-img

Understanding hereditary risks

Our hereditary cancer solutions help close the gap between the unknown and the path forward. A complete portfolio of hereditary cancer tests, services, and expert analysis from our on-staff genetic counselors help you understand your patients' risk and are the first step in our approach to supporting a patient's cancer journey.

 

Tests include:

  • Comprehensive and guideline-based hereditary cancer panels
  • Cancer-specific panels
  • Hereditary cancer syndrome panels
  • Single-gene and single-site tests    

Haystack MRD™: Purpose-built for personalized precision

Gain deep insights for confident treatment decisions with ultrasensitive circulating tumor DNA (ctDNA) testing.

Learn more

Get in touch

775

* indicates required

Experience the power of precision in every cancer diagnosis

Optimal outcomes in oncology start with excellent diagnostics, but it doesn't stop there. At Quest, we go beyond the test as your single-source solution, delivering reliable results, efficient processes, and world-class expertise across the cancer care continuum.

Hereditary genetic risk and colorectal cancer testing solutions

A comprehensive portfolio with testing from routine to advanced, including:

  • Colorectal cancer screening
  • Prostate cancer screening
  • Complete portfolio of hereditary cancer tests and services to support improved actionability, efficiency, and patient engagement

Subspecialized pathology solutions

Advanced pathology solutions that include:

  • 400+ subspecialized pathologists
  • Comprehensive bone marrow workup with integrated summary report
  • Digital pathology
  • Technical component (TC)/professional component (PC) and global solutions
  • Next-generation sequencing (NGS) for hematology

Molecular testing for evaluating prognosis:
  • MelaNodal Predict™
  • LeukoVantage® Myeloid Neoplasm Panels
  • Acute Myeloid Leukemia (AML) Rapid Mutation Panel
  • Prosigna® Breast Cancer Prognostic Gene Signature Assay

Precision medicine companion/complementary diagnosis, solid tumor NGS, heme NGS, hereditary cancer NGS

Solutions for solid tumor and hematologic malignancies:

  • Disease-specific panels
  • NCI trial matching
  • Pan-tumor biomarkers
  • NGS for solid tumors, hematology, and hereditary cancer
  • Comprehensive genomic profiling with 500+ genes: both RNA and DNA sequencing with over 50 gene fusions and copy number variants

Routine testing post treatment assessing therapy impact

High-precision minimal residual disease (MRD) testing:

  • Haystack MRD™ for solid tumors
  • Heme MRD with molecular and flow cytometry solutions

Resources and Insights


See how we are committed to the future of cancer care

View all resources